当前位置: X-MOL 学术Leukemia › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
CRISPR/Cas9 edited NSG mice as PDX models of human leukemia to address the role of niche-derived SPARC
Leukemia ( IF 11.4 ) Pub Date : 2017-12-06 , DOI: 10.1038/leu.2017.346
I Tirado-Gonzalez 1 , E Czlonka 1 , A Nevmerzhitskaya 1 , D Soetopo 1 , E Bergonzani 1 , A Mahmoud 1 , A Contreras 1 , I Jeremias 2, 3 , U Platzbecker 4, 5 , J P Bourquin 6 , U Kloz 6 , F Van der Hoeven 7 , H Medyouf 1, 8, 9
Affiliation  

CRISPR/Cas9 edited NSG mice as PDX models of human leukemia to address the role of niche-derived SPARC

CRISPR/Cas9 edited <i>NSG</i> mice as PDX models of human leukemia to address the role of niche-derived SPARC, Published online: 06 December 2017; doi:10.1038/leu.2017.346

CRISPR/Cas9 edited NSG mice as PDX models of human leukemia to address the role of niche-derived SPARC


中文翻译:

CRISPR/Cas9 编辑 NSG 小鼠作为人类白血病的 PDX 模型,以解决利基衍生 SPARC 的作用

CRISPR/Cas9 编辑NSG小鼠作为人类白血病的 PDX 模型,以解决利基衍生 SPARC 的作用

CRISPR/Cas9 编辑 <i>NSG</i> 小鼠作为人类白血病的 PDX 模型,以解决小生境衍生 SPARC 的作用,在线发布:2017 年 12 月 6 日;doi:10.1038/leu.2017.346

CRISPR/Cas9 编辑NSG小鼠作为人类白血病的 PDX 模型,以解决利基衍生 SPARC 的作用
更新日期:2017-12-06
down
wechat
bug